MedTrace Logo

Brilliant Blue Versus Indocyanine Green

NCT01083004 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2011-04-18

No results posted yet for this study

Summary

A study of non-inferiority design comparing brilliant blue and indocyanine green as intraoperative dye in macular pucker and macular hole.

Conditions

  • Macular Pucker
  • Macular Hole
  • Vitreoretinal Surgery

Interventions

PROCEDURE

Indocyanine green

Using indocyanine green as intraoperative dye

PROCEDURE

Brilliant blue arm

Using brilliant blue as intraoperative dye

Sponsors & Collaborators

  • University of Cologne

    lead OTHER

Principal Investigators

  • Bernd Kirchhof, MD · University of Cologne, Center of Ophthalmology, 50924 Cologne, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2011-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01083004 on ClinicalTrials.gov